The IC50s of compound 11 in A375 and SK-Mel-28 melanoma cells were 0.088 μM and 0.07 μM, respectively (Figure 3d, Table 1), which are more potent than commercially available APE/Ref-1 redox inhibitors. The gene discussed is APEX1; the disease is melanoma.